Michael S. Dobbie

1.7k total citations
22 papers, 1.1k citations indexed

About

Michael S. Dobbie is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Michael S. Dobbie has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Physiology. Recurrent topics in Michael S. Dobbie's work include Barrier Structure and Function Studies (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Michael S. Dobbie is often cited by papers focused on Barrier Structure and Function Studies (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Michael S. Dobbie collaborates with scholars based in United Kingdom, Australia and Switzerland. Michael S. Dobbie's co-authors include N. Joan Abbott, Gunter Kuhnle, Anna R. Proteggente, Kuresh Youdim, Catherine Rice‐Evans, Roger D. Hurst, Robert Surtees, R. Surtees, Nigel Klein and Kevin Marsh and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Brain Research.

In The Last Decade

Michael S. Dobbie

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Dobbie United Kingdom 13 441 207 187 152 118 22 1.1k
Yisong Qian China 24 709 1.6× 204 1.0× 102 0.5× 192 1.3× 74 0.6× 50 1.5k
Masayuki Fukui United States 19 733 1.7× 110 0.5× 161 0.9× 161 1.1× 87 0.7× 27 1.5k
Sachiko Kanai Japan 18 293 0.7× 98 0.5× 320 1.7× 156 1.0× 59 0.5× 73 1.2k
Wycliffe O. Opii United States 10 627 1.4× 138 0.7× 79 0.4× 376 2.5× 83 0.7× 12 1.3k
Yasuko Kitagishi Japan 23 1.0k 2.3× 114 0.6× 160 0.9× 299 2.0× 44 0.4× 55 1.9k
Soledad Miranda Chile 12 459 1.0× 72 0.3× 131 0.7× 283 1.9× 92 0.8× 12 936
Ron J. Bouchard United States 24 1.1k 2.5× 145 0.7× 119 0.6× 263 1.7× 41 0.3× 37 1.9k
Weidong Huang China 16 561 1.3× 99 0.5× 67 0.4× 196 1.3× 31 0.3× 42 1.0k
Marzia Perluigi Italy 18 711 1.6× 108 0.5× 49 0.3× 394 2.6× 86 0.7× 24 1.3k
Marta Salinas Spain 11 1.3k 2.9× 157 0.8× 75 0.4× 261 1.7× 81 0.7× 11 1.8k

Countries citing papers authored by Michael S. Dobbie

Since Specialization
Citations

This map shows the geographic impact of Michael S. Dobbie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Dobbie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Dobbie more than expected).

Fields of papers citing papers by Michael S. Dobbie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Dobbie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Dobbie. The network helps show where Michael S. Dobbie may publish in the future.

Co-authorship network of co-authors of Michael S. Dobbie

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Dobbie. A scholar is included among the top collaborators of Michael S. Dobbie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Dobbie. Michael S. Dobbie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lutz, Christian, Michael S. Dobbie, Luigi Terracciano, et al.. (2023). Ribociclib-induced liver injury: a case report. Frontiers in Oncology. 13. 1256783–1256783. 13 indexed citations
2.
3.
Dobbie, Michael S., Xiang Gao, Ki‐Hoan Nam, et al.. (2021). Asian Mouse Mutagenesis Resource Association (AMMRA): mouse genetics and laboratory animal resources in the Asia Pacific. Mammalian Genome. 33(1). 192–202. 2 indexed citations
4.
Vlajnic, Tatjana, Marcus Vetter, Katharina Glatz, et al.. (2019). Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response. Journal for ImmunoTherapy of Cancer. 7(1). 281–281. 12 indexed citations
5.
Miller, Kerry A., Casey Ah-Cann, Tiong Yang Tan, et al.. (2013). Cauli: A Mouse Strain with an Ift140 Mutation That Results in a Skeletal Ciliopathy Modelling Jeune Syndrome. PLoS Genetics. 9(8). e1003746–e1003746. 46 indexed citations
6.
Caruana, Georgina, Peter G. Farlie, Adam H. Hart, et al.. (2013). Genome-Wide ENU Mutagenesis in Combination with High Density SNP Analysis and Exome Sequencing Provides Rapid Identification of Novel Mouse Models of Developmental Disease. PLoS ONE. 8(3). e55429–e55429. 14 indexed citations
7.
Liu, Xin, Michael S. Dobbie, Belinda Whittle, et al.. (2011). ENU Mutagenesis Screen to Establish Motor Phenotypes in Wild‐Type Mice and Modifiers of a Pre‐Existing Motor Phenotype in Tau Mutant Mice. BioMed Research International. 2011(1). 130947–130947. 9 indexed citations
8.
Youdim, Kuresh, Michael S. Dobbie, Gunter Kuhnle, et al.. (2003). Interaction between flavonoids and the blood–brain barrier:in vitrostudies. Journal of Neurochemistry. 85(1). 180–192. 450 indexed citations
9.
Cooper, Chris E., Nathan Davies, Laura Canevari, et al.. (2003). Nitric oxide and peroxynitrite cause irreversible increases in the Km for oxygen of mitochondrial cytochrome oxidase: in vitro and in vivo studies. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1607(1). 27–34. 59 indexed citations
10.
Abbott, N. Joan, E.U. Khan, Andreas Reichel, et al.. (2002). Drug Resistance in Epilepsy: The Role of the Blood–Brain Barrier. Novartis Foundation symposium. 38–53. 88 indexed citations
11.
Dobbie, Michael S., et al.. (2001). A comparison of the induction of immortalized endothelial cell impermeability by astrocytes. Neuroreport. 12(7). 1329–1334. 43 indexed citations
12.
Hughes, G R, et al.. (2000). Serum antibodies from patients with neuropsychiatric systemic lupus erythematosus cause activation and damage to an in vitro blood-brain barrier model. The Journal of Physiology. 525.
13.
Dobbie, Michael S., Jane Crawley, C Waruiru, Kevin Marsh, & R. Surtees. (2000). Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism?. American Journal of Tropical Medicine and Hygiene. 62(2). 284–290. 70 indexed citations
14.
Dobbie, Michael S., Roger D. Hurst, Nigel Klein, & Robert Surtees. (1999). Upregulation of intercellular adhesion molecule-1 expression on human endothelial cells by tumour necrosis factor-α in an in vitro model of the blood–brain barrier. Brain Research. 830(2). 330–336. 73 indexed citations
15.
McCarthy, Gillian, et al.. (1999). GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness. Journal of Neurology Neurosurgery & Psychiatry. 66(1). 86–89. 25 indexed citations
16.
Hurst, Roger D., et al.. (1998). Decreased endothelial cell glutathione and increased sensitivity to oxidative stress in an in vitro blood–brain barrier model system. Brain Research. 802(1-2). 232–240. 31 indexed citations
17.
Dobbie, Michael S. & Robert Surtees. (1997). Concentrations of quinolinic acid in cerebrospinal fluid measured by gas chromatography and electron-impact ionisation mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 696(1). 53–58. 9 indexed citations
18.
Jones, A. R., et al.. (1996). Renal and Spermatozoal Toxicity of α-Bromohydrin, 3-Bromolactate and 3-Bromopyruvate. Journal of Applied Toxicology. 16(1). 57–63. 10 indexed citations
19.
Jones, A. R. & Michael S. Dobbie. (1991). The male antifertility activity of 6-Chloro-6-deoxyglucose. Contraception. 44(6). 649–655. 6 indexed citations
20.
Dobbie, Michael S., et al.. (1988). Is the Nephrotoxicity of (R)-3-Chlorolactate in the Rat Caused by 3-Chloropyruvate?. Xenobiotica. 18(12). 1389–1399. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yisong Qian Breakdown of academic impact, for papers by Masayuki Fukui Breakdown of academic impact, for papers by Sachiko Kanai Breakdown of academic impact, for papers by Wycliffe O. Opii Breakdown of academic impact, for papers by Yasuko Kitagishi Breakdown of academic impact, for papers by Soledad Miranda Breakdown of academic impact, for papers by Ron J. Bouchard Breakdown of academic impact, for papers by Weidong Huang Breakdown of academic impact, for papers by Marzia Perluigi Breakdown of academic impact, for papers by Marta Salinas
Rankless by CCL
2026